G. Walmsley Graham

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by G. Walmsley Graham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. Director Common Stock 1,800,000 $5,724,000 $3.18 13 Dec 2024 Indirect
Akero Therapeutics, Inc. Director Common Stock 0 $0 $54.31 09 Dec 2025 Direct
Akero Therapeutics, Inc. Director Common Stock 0 $0 $54.31 09 Dec 2025 Indirect
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 24,150 11 Jun 2025 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock option (right to buy) 12,004 11 Jun 2021 Direct
Akero Therapeutics, Inc. Director Stock Option (Right to Buy) 0 09 Dec 2025 Direct

Insider Reports Filed by G. Walmsley Graham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKRO Akero Therapeutics, Inc. 09 Dec 2025 4 $0 4 Director 09 Dec 2025, 10:17
AKRO Akero Therapeutics, Inc. 08 Oct 2025 10 +$1,866,155 4 Director 10 Oct 2025, 19:48
OLMA Olema Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 17:00
AKRO Akero Therapeutics, Inc. 03 Jun 2025 1 $0 4 Director 05 Jun 2025, 16:05
AKRO Akero Therapeutics, Inc. 25 Mar 2025 3 +$8,787,921 4 Director 27 Mar 2025, 19:42
AKRO Akero Therapeutics, Inc. 30 Jan 2025 1 +$9,600,000 4 Director 07 Feb 2025, 19:54
OLMA Olema Pharmaceuticals, Inc. 13 Dec 2024 0 $0 4/A Director 13 May 2025, 19:14
OLMA Olema Pharmaceuticals, Inc. 13 Dec 2024 2 $0 4/A Director 18 Dec 2024, 18:52
OLMA Olema Pharmaceuticals, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 17:00
AKRO Akero Therapeutics, Inc. 08 Jun 2024 1 $0 4 Director 11 Jun 2024, 17:29
OLMA Olema Pharmaceuticals, Inc. 04 Jun 2024 2 -$17,448,750 4/A Director 26 Nov 2024, 16:48
AKRO Akero Therapeutics, Inc. 08 Dec 2023 2 +$1,982,940 4 Director 11 Dec 2023, 21:06
AKRO Akero Therapeutics, Inc. 30 Nov 2023 2 +$1,694,565 4 Director 05 Dec 2023, 08:37
OLMA Olema Pharmaceuticals, Inc. 12 Sep 2023 2 -$17,448,750 4 Director 06 Jun 2024, 17:01
OLMA Olema Pharmaceuticals, Inc. 12 Sep 2023 4 +$6,871,279 4 Director 18 Dec 2023, 18:30
AKRO Akero Therapeutics, Inc. 08 Aug 2023 1 +$1,051,475 4 Director 10 Aug 2023, 16:46
AKRO Akero Therapeutics, Inc. 28 Jul 2023 2 +$2,362,234 4 Director 01 Aug 2023, 19:52
AKRO Akero Therapeutics, Inc. 23 Jun 2023 1 $0 4 Director 27 Jun 2023, 17:48
OLMA Olema Pharmaceuticals, Inc. 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 17:00
AKRO Akero Therapeutics, Inc. 19 Sep 2022 2 +$15,440,000 4/A Director 15 Jun 2023, 21:26
OLMA Olema Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4/A Director 27 Jun 2022, 17:10
OLMA Olema Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 19:25
AKRO Akero Therapeutics, Inc. 02 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:06
ALXO ALX ONCOLOGY HOLDINGS INC 11 Jun 2021 1 $0 4 Director 15 Jun 2021, 19:03
OLMA Olema Pharmaceuticals, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 18:38
AKRO Akero Therapeutics, Inc. 01 Jun 2021 4 $0 4 Director 03 Jun 2021, 17:55